Depression spending increases but outcomes do not, study finds

The options for treating depression have expanded far beyond a simple prescription to buy Paxil in recent years. But new research suggests that this may not necessarily lead to better outcomes.

The options for treating depression have expanded far beyond a simple prescription to buy Paxil in recent years. But new research suggests that this may not necessarily lead to better outcomes.

A team of researchers from Harvard Medical School analyzed Medicaid spending trends from 1996 through 2005. The results showed that spending on depression increased by 29 percent during this time period. However, indicators of quality were more mixed, suggesting that the extra spending did little to improve care.

The results showed that a major reason for the dramatic increase in spending resulted from a greater use of antipsychotic medications, which began before the study period in the 1980s, the researchers said. These medications may have different effects than standard antidepressants like Paxil.

"In summary, during the 10-year period between 1996 and 2005, we found a substantial increase in spending for patients with depression, with minimal improvements in quality of care," the researchers wrote. "Our findings underscore the importance of continued efforts to improve quality of care for individuals with depression."

See also ...

IMPORTANT DISCLOSURE: All medical content and news articles on this website is supplied by an independent third party company. While the information can be useful, this website relies on others for its creation and cannot guarantee the accuracy, medical efficacy, or reliability of the information provided. In all circumstances, you should always seek the advice of your physician and/or other qualified health professional(s) for drug, medical condition, or treatment advice. This website does not provide any medical advice. The content provided on this website is not a substitute for professional medical advice, diagnosis or treatment.

CanadianPharmacyMeds.com facilitates the review of your prescriptions and your general health. We forward all prescriptions to be filled at affiliated CIPA certified licensed Canadian pharmacies and PharmacyChecker certified international fulfillment centers. To verify a Canadian pharmacy CIPA certification or Pharmacy Checker certification, please click on their respective links. In addition to dispensing from our Canadian dispensing pharmacy, medication orders are also filled and shipped from international fulfillment centers that are approved by the regulatory bodies from their respective countries. Medication orders are filled and shipped from approved fulfillment centers around the world including, but not limited to, Canada, Singapore, United Kingdom, New Zealand, Turkey, Mauritius, India, Australia, and the United States. The items in your order may be filled and shipped from any one of the above jurisdictions. The products are sourced from various countries as well as those listed above. All of our affiliated fulfillment centers have been approved by the regulatory bodies from their respective countries.

Healthcare

Clinical Drug Trials

Canada Drugs

Canadian Pharmacy

Canadian Pharmacy

Clinical Drug Trials

Depression spending increases but outcomes do not, study finds